… some of the potential CD-based chemotherapeutic drug delivery systems. In so-doing, …
chemotherapeutic drug carrier has been provided. Subsequently, the application of CD as a drug …

… -6-FA-appended β-CyD possessing two caproic acids as a spacer between FA … β-CyD
molecules (Fol-c 2 -β-CyD) in this study. Then, the potential of this conjugate as an antitumor drug …

… The purpose of this study was to evaluate the influence of polymer size, drug loading,
and linker structure on the antitumor efficacy and toxicity of the β-cyclodextrin-based polymer−CPT …

… An important approach in this regard is the use of combination of cyclodextrin and … anticancer
drugs, their complexation with cyclodextrins, loading/encapsulating the complexed drugs …

… A novel drug carrier based on hydroxypropyl-β-cyclodextrin (HP-β-CD) modified carboxylated
graphene oxide (GO-COOH) was designed to incorporate anti-cancer drug paclitaxel (PTX…

… of β-CD core allows for the formation of inclusion complex with a model anticancer drug: …
DOX release changes in the order of DPE core micelles >β-CD core micelles >SCMs. The …

… of anticancer drug property of Etoposide with β-cyclodextrin. … aqueous solubility of the
anticancer drug Etoposide. The … to the anticancer drug Etoposide with β-cyclodextrin complex is …

The tumor targeting properties of a new drug carrier synthesized by bioconjugation of folic
acid (FA) to β-cyclodextrins through a poly(ethylene glycol) (PEG) spacer (CD−PEG−FA) were …

… In this review, we only evaluated animal studies conducted on anticancer drugs complexed
with CDs. Among the twelve studies, six investigated the chemopreventive properties of CD-…

… We now consider the results obtained for Acivicin, the most polar antitumor agents included
in the present study ( μ=3.14 D as obtained from the MD simulation on the isolated molecule)…